ZB Wisco Revenue and Competitors
Estimated Revenue & Valuation
- ZB Wisco's estimated annual revenue is currently $2.8M per year.
- ZB Wisco's estimated revenue per employee is $251,000
Employee Data
- ZB Wisco has 11 Employees.
- ZB Wisco grew their employee count by 0% last year.
ZB Wisco's People
Name | Title | Email/Phone |
---|
ZB Wisco Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.9M | 39 | -5% | $50.6M | N/A |
#2 | $16.8M | 67 | -7% | N/A | N/A |
#3 | $30.1M | 120 | 29% | N/A | N/A |
#4 | $88.6M | 353 | 0% | N/A | N/A |
#5 | $8.3M | 33 | 14% | N/A | N/A |
#6 | $34.4M | 137 | 8% | N/A | N/A |
#7 | $78.8M | 314 | -25% | N/A | N/A |
#8 | $15.1M | 60 | 7% | N/A | N/A |
#9 | $56.2M | 224 | 9% | N/A | N/A |
#10 | $12M | 48 | -2% | N/A | N/A |
What Is ZB Wisco?
OVERVIEW: ZBWisco is a Sales, Service, Support, and Logistics company specializing in distribution of medical devices and equipment. ZBWisco continues a long history of success in this market with existing history and lineage with ZimmerBiomet dating back to 1957. MISSION: Support HCPs to help improve clinical outcomes of patients they serve. We do this through the highest level of service, professionalism, and ethical business practices. CORE: Values: Integrity, Passion, Excellence, Caring, Team Work, Charity, Pride & Respect. VISION: Statement: To deliver best in class customer experience in the Medical Device Industry.
keywords:N/AN/A
Total Funding
11
Number of Employees
$2.8M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
ZB Wisco News
... z.B. bei Schulkooperationen, zivilgesellschaftlicher Zusammenarbeit, ... aber lange Zeit dem Stahlkonzern Wuhan Iron and Steel Corporation (WISCO).
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.2M | 12 | N/A | N/A |
#2 | $1.2M | 14 | 0% | N/A |
#3 | $1.4M | 16 | 60% | N/A |
#4 | $5.3M | 26 | 13% | N/A |
#5 | $4.8M | 28 | 8% | N/A |